25 May 2013
Keywords: fda, backs, pfizer, dofetilide, launch, slated, early
Article | 11 October 1999
The US Food and Drug Administration has given its backing to Pfizer'sTikosyn (dofetilide), the first new oral antiarrythmic drug for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.